Patanjali’s Renogrit protects kidneys during cancer treatment

A recent study highlights Patanjali's Renogrit as a promising treatment for kidney damage caused by the cancer drug cisplatin. The research was published in the Scientific Reports journal and recognized as one of the top 100 papers of 2024. Renogrit is made from a blend of seven herbs. The study shows that it can protect renal tubular cells from injury without reducing the effectiveness of cisplatin in fighting cancer. This finding is significant for cancer patients who may suffer from kidney issues due to their treatment. Researchers hope this discovery will lead to better treatment options for those affected by the side effects of cancer drugs. The acknowledgment of the paper underscores its importance in the ongoing battle against cancer and its complications.